Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.67 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.66 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.66 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.57 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.57 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.57 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12423201 | 0.86 | MAOB (0.69) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL17644774 | 0.86 | MAOB (0.68) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL10897051 | 0.86 | LMNA (0.65) | MAOBPARP15PARP10PARP14KDM4E | |
| SCHEMBL7025478 | 0.85 | MAOB (0.54) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL15079383 | 0.85 | MAOB (0.51) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL7239415 | 0.84 | MAOB (0.58) | MAOBPARP15PARP10PARP14NPC1 | |
| Hydrochloric Acid SCHEMBL28551904 | 0.84 | MAOB (0.69) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL2937570 | 0.84 | MAOB (0.71) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL2950518 | 0.83 | MAOB (0.71) | MAOBPARP15PARP10PARP14NPC1 | |
| SCHEMBL311630 | 0.83 | MAOB (0.65) | MAOBPARP15PARP10PARP14NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116265458-A | Benzothiophene derivative, preparation method and application thereof | 中国科学院上海药物研究所 | 2023-06-20 | — | — | CN | disclosed |
| WO-2019170088-A1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINAZOLINE TYPE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京赛特明强医药科技有限公司 | 2019-09-12 | — | — | WO | disclosed |
| EP-2036878-B1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-7745669-B2 | Process for production of alcohol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-29 | — | — | US | disclosed |
| US-20090259074-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-10-15 | — | — | US | disclosed |
| EP-2036878-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2009-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090259074-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | XDH, ADH5, ADH1A | MAOB 499/4885PARP15 2809/4885PARP10 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.